Skip to main content
Signal8

VSEE HEALTH, INC. (VSEE) Form 8-K — Jul 7, 2026

$VSEEForm 8-KItems 1.01, 2.03, 3.02, 9.01Filed Jul 7, 2026, 8:00 AM ET0001185185-26-002823Original filing

VSee Health, Inc. entered into two separate securities purchase agreements for unsecured convertible note financing, raising an aggregate principal amount of $575,550. The company issued a $280,000 note to ClearThink Capital Partners and a $295,550 note to Vanquish Funding Group, both of which include significant original issue discounts of 10% and 12%, respectively. The ClearThink note matures in June 2027 and is convertible into common stock at 85% of the lowest closing price over the ten trading days prior to conversion notice, subject to a $0.01 floor price.

Key figures

Debt Amount
$575,550
Vanquish Principal
$295,550
Clear Think Principal
$280,000
Conversion Floor Price
$0.01
Vanquish Interest Rate
12%
Vanquish Maturity Date
April 15, 2027
Clear Think Interest Rate
10%
Clear Think Maturity Date
June 22, 2027
Vanquish Conversion Discount
75%
Clear Think Conversion Discount
85%
Vanquish Original Issue Discount
$38,550
Clear Think Original Issue Discount
$30,000
Vanquish Additional Tranche Capacity
$2,050,000

Price after filing

1 day: -3.6%7 days: -10.5%30 days: -54.4%

Close on the filing date to close N calendar days later (from $0.11). Historical, not a forecast.

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.